“One-Two Punch” Combination Therapy

May is National Cancer Research Month!

For National Cancer Research Month, we are highlighting some fantastic research advancements your support has helped make possible. With generous partners like you, the Pancreatic Cancer Action Network has awarded over $35 million in research grants to advance science and medicine and improve outcomes for patients facing pancreatic cancer. Here are a few examples of your impact!

We are supporting the development of a “one-two punch” combination therapy to knock out cancer. This dual-action therapy first tricks pancreatic cancer cells into poisoning themselves and then stops the cells from repairing the poison’s damage. The novel combination treatment will enter clinical trials in 2017.

One of the goals of our competitive Research Grants Program is to fund translational research – to help move vital work from the lab to the clinic to reach patients. Dr. Boothman’s work is a wonderful example of how donors partner with the Pancreatic Cancer Action Network to help turn new ideas into novel treatment approaches for patients.

Did you know?

Since 2003, we’ve awarded over $35 million through a competitive peer-reviewed process -- including 142 grants to 143 researchers at 55 institutions across the country.

Over our first decade of funding research, we supported 92 grantees who went on to publish 1,191 articles in peer-reviewed journals, cited more than 13,000 times. These grantees have leveraged each $1 from us to gain $8.28 in subsequent pancreatic cancer research funding.

New grantees will be announced in the summer of 2017. New grant opportunities open in fall of 2017.

What does National Cancer Research Month mean to you? Join the conversation online by tagging @PanCAN and using the hashtag #NCRM17!